Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
233.18
145.24
109.46
227.49
198.32
175.34
164.25
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
233.18
145.24
109.46
227.49
198.32
175.34
164.25
Raw Material Cost
51.30
49.98
25.14
33.40
28.56
25.64
23.55
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
11.18
11.33
11.01
20.14
19.05
18.83
9.81
Selling and Distribution Expenses
220.56
234.27
183.06
124.75
114.52
109.70
86.60
Other Expenses
20.63
22.64
21.01
18.87
11.16
12.10
11.30
Total Expenditure (Excl Depreciation)
489.36
521.98
429.27
367.00
273.70
275.15
232.94
Operating Profit (PBDIT) excl Other Income
-256.2
-376.70000000000005
-319.8
-139.5
-75.4
-99.80000000000001
-68.7
Other Income
14.50
23.36
7.25
2.22
6.42
9.74
5.03
Operating Profit (PBDIT)
-198.13
-314.85
-291.84
-110.66
-43.17
-69.66
-45.00
Interest
11.18
11.33
11.01
20.14
19.05
18.83
9.81
Exceptional Items
-67.64
-11.39
-7.58
-22.26
-100.79
-37.55
-28.39
Gross Profit (PBDT)
181.88
95.26
84.32
194.09
169.76
149.70
140.69
Depreciation
43.55
38.53
20.72
26.62
25.79
20.41
18.67
Profit Before Tax
-320.51
-376.11
-331.15
-179.68
-188.79
-146.45
-101.87
Tax
0.12
0.22
0.31
0.41
-19.36
-0.02
0.81
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-320.63
-376.33
-331.47
-180.09
-169.43
-146.43
-102.68
Extraordinary Items
0.00
-0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-320.63
-376.33
-331.47
-180.09
-169.43
-146.43
-102.68
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-320.63
-376.33
-331.47
-180.09
-169.43
-146.43
-102.68
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
59.08
200.81
42.85
302.11
211.21
221.20
318.25
Earnings per share (EPS)
-4.08
-4.54
-4.37
-3.01
-3.56
-3.46
-2.54
Diluted Earnings per share
-4.08
-4.54
-4.37
-3.01
-3.56
-3.46
-2.54
Operating Profit Margin (Excl OI)
-109.87%
-259.4%
-292.17%
-61.32%
-38.01%
-56.92%
-41.82%
Gross Profit Margin
-118.78%
-232.43%
-283.61%
-67.28%
-82.19%
-71.88%
-50.66%
PAT Margin
-137.51%
-259.11%
-302.82%
-79.16%
-85.43%
-83.51%
-62.51%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 60.61% vs 32.60% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 14.80% vs -13.51% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 37.14% vs -13.07% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is -0.88% vs 2.73% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Travere Therapeutics, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
233.18
0.30
232.88
77,626.67%
Other Operating Income
0.00
0.00
0.00
Total Operating income
233.18
0.30
232.88
77,626.67%
Raw Material Cost
51.30
1.24
50.06
4,037.10%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
11.18
3.05
8.13
266.56%
Selling and Distribution Expenses
220.56
60.38
160.18
265.29%
Other Expenses
20.63
23.47
-2.84
-12.10%
Total Expenditure (Excl Depreciation)
489.36
299.34
190.02
63.48%
Operating Profit (PBDIT) excl Other Income
-256.18
-299.03
42.85
14.33%
Other Income
14.50
32.13
-17.63
-54.87%
Operating Profit (PBDIT)
-198.13
-265.66
67.53
25.42%
Interest
11.18
3.05
8.13
266.56%
Exceptional Items
-67.64
0.00
-67.64
Gross Profit (PBDT)
181.88
-0.94
182.82
19,448.94%
Depreciation
43.55
1.24
42.31
3,412.10%
Profit Before Tax
-320.51
-269.95
-50.56
-18.73%
Tax
0.12
0.00
0.12
Provisions and contingencies
0
0
0.00
Profit After Tax
-320.63
-208.56
-112.07
-53.74%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-320.63
-208.56
-112.07
-53.74%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-320.63
-208.56
-112.07
-53.74%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
59.08
482.75
-423.67
-87.76%
Earnings per share (EPS)
-4.08
-3.07
-1.01
-32.90%
Diluted Earnings per share
-4.08
-3.07
-1.01
-32.90%
Operating Profit Margin (Excl OI)
-109.87%
-99,018.21%
0.00
98,908.34%
Gross Profit Margin
-118.78%
-88,976.49%
0.00
88,857.71%
PAT Margin
-137.51%
-69,059.60%
0.00
68,922.09%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 23.32 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 60.61% vs 32.60% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit -32.06 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 14.80% vs -13.51% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -21.26 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 37.14% vs -13.07% in Dec 2023
Annual - Interest
Interest 1.12 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -0.88% vs 2.73% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -109.87%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






